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Abstract
Background: There is evidence to suggest that the broad discrepancy in the ratio of males to females with
diagnosed ADHD is due, at least in part, to lack of recognition and/or referral bias in females. Studies suggest that
females with ADHD present with differences in their profile of symptoms, comorbidity and associated functioning
compared with males. This consensus aims to provide a better understanding of females with ADHD in order to
improve recognition and referral. Comprehensive assessment and appropriate treatment is hoped to enhance
longer-term clinical outcomes and patient wellbeing for females with ADHD.
Methods: The United Kingdom ADHD Partnership hosted a meeting of experts to discuss symptom presentation,
triggers for referral, assessment, treatment and multi-agency liaison for females with ADHD across the lifespan.
Results: A consensus was reached offering practical guidance to support medical and mental health practitioners
working with females with ADHD. The potential challenges of working with this patient group were identified, as
well as specific barriers that may hinder recognition. These included symptomatic differences, gender biases,
comorbidities and the compensatory strategies that may mask or overshadow underlying symptoms of ADHD.
Furthermore, we determined the broader needs of these patients and considered how multi-agency liaison may
provide the support to meet them.
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Conclusions: This practical approach based upon expert consensus will inform effective identification, treatment
and support of girls and women with ADHD. It is important to move away from the prevalent perspective that
ADHD is a behavioural disorder and attend to the more subtle and/or internalised presentation that is common in
females. It is essential to adopt a lifespan model of care to support the complex transitions experienced by females
that occur in parallel to change in clinical presentation and social circumstances. Treatment with pharmacological
and psychological interventions is expected to have a positive impact leading to increased productivity, decreased
resource utilization and most importantly, improved long-term outcomes for girls and women.
Keywords: Attention-deficit/hyperactivity disorder (ADHD), Female, Girls, Women, Identification, Treatment,
Interventions, Comorbidity, Consensus, UKAP
Background
Attention-deficit/hyperactivity disorder (ADHD) is a
common neurodevelopmental condition described in
diagnostic classification systems (ICD-10, DSM-5 [1, 2]).
It is characterised by difficulties in two subdomains: in-
attention, and hyperactivity-impulsivity. Three primary
subtypes can be identified: predominantly inattentive,
hyperactive-impulsive, and combined presentations.
Symptoms persist over time, pervade across situations
and cause significant impairment [3].
ADHD is present in childhood and symptoms tend to
decline with increasing age [4], with consistent reduc-
tions documented in hyperactive-impulsive symptoms
but more mixed results regarding the decline in inatten-
tive symptoms [5–7]. This trajectory does not appear to
be different in affected males or females [6, 8]. A meta-
analysis of longitudinal studies published in 2005
showed that up to one-third of childhood cases contin-
ued to meet full diagnostic criteria into their 20s, with
around 65% continuing to experience impairing symp-
toms [9]. More recent studies in large clinical cohorts
indicate that persistence of ADHD into adulthood may
be much more common. Two studies from child mental
health clinics in the UK and the Netherlands have re-
ported persistence in around 80% of children with the
combined type presentation into early adulthood [10,
11], potentially relating to the high severity of ADHD
in this group and the use of more objective ratings
[12]. The proportion meeting full diagnostic criteria
for ADHD then continues to decline in adult samples
[13]. Simultaneously, experiences of ADHD symptoms
often change over the course of development: hyper-
activity may be replaced by feelings of ‘inner restless-
ness’ and discomfort; inattention may manifest as
difficulty completing chores or work-based activities
(e.g. filling out forms, remembering appointments,
meeting deadlines) [1].
Psychiatric comorbidity is very common, which may
complicate identification and treatment [14]. In chil-
dren with ADHD this includes conduct disorder
(CD), oppositional defiant disorder (ODD), disruptive
mood dysregulation disorder, autism spectrum dis-
order (ASD), developmental coordination disorder, tic
disorders, anxiety and depressive disorders, reading
disorders, and learning and language disorders [15–
17]. Comorbid conditions are also extremely common
in adults and include ASD, anxiety and depressive
disorders, bipolar disorder, eating disorders, obsessive
compulsive disorder, substance use disorders, person-
ality disorders, and impulse control disorders [18, 19].
Prevalence of ADHD is estimated at 7.1% in children
and adolescents [20], and 2.5-5% in adults [4, 21], and
around 2.8% in older adults [22]. Sex differences in the
prevalence of ADHD are well documented. Clinical re-
ferrals in boys typically exceed those for girls, with ratios
ranging from 3-1 to 16-1 [23]. The discrepancy of
ADHD rates in community samples remains significant,
although it is less extreme, at around a 3-1 ratio of boys
to girls [4]. Nevertheless the discrepancy in the sex-ratio
between clinic and community samples highlights that a
large number of girls with ADHD are likely to remain
unidentified and untreated, with implications for long-
term social, educational and mental health outcomes
[24].
This disparity in prevalence between boys and girls
may stem from a variety of potential factors. The contri-
bution of greater genetic vulnerability, endocrine factors,
psychosocial contributors, or a propensity to respond
negatively to certain early life stressors in boys have been
proposed or investigated as potential contributors to
sexual dimorphism in prevalence and presentation [25,
26]. Whilst in childhood there is a clear male preponder-
ance of ADHD, in adult samples sex differences in
prevalence are more modest or absent [21, 27–29]. This
may be due to a variety of factors, with potential contri-
butions from the greater reliance on self-report in older
samples, greater persistence in females alongside in-
creased levels of remission in males, and potentially
more common late onset cases in females [25, 26, 28].
Comprehensive views of the aetiology of ADHD in-
corporate biological, environmental and cultural per-
spectives and influences [25]. Substantial genetic
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influences have been identified in ADHD [30]. Individ-
uals who have ADHD are more likely to have children,
parents and/or siblings with ADHD [31, 32]. The ‘female
protective effect’ theory suggests that girls and women
may need to reach a higher threshold of genetic and en-
vironmental exposures for ADHD to be expressed,
thereby accounting for the lower prevalence in females
and the higher familial transmission rates seen in fam-
ilies where females are affected [33, 34]. Research sug-
gests that siblings of affected girls have more ADHD
symptoms compared with siblings of affected boys [33,
34].
There is increasing recognition that females with
ADHD show a somewhat modified set of behaviours,
symptoms and comorbidities when compared with males
with ADHD; they are less likely to be identified and re-
ferred for assessment and thus their needs are less likely
to be met. It is unknown how often a diagnosis of
ADHD is being missed or misdiagnosed in females, but
it has become clear that a better understanding of
ADHD in girls and women is needed if we are to im-
prove their longer-term wellbeing and functional
and clinical outcomes [35, 36].
This report provides a selective review the research lit-
erature on ADHD in girls and women, and aims to pro-
vide guidance to improve identification, treatment and
support for girls and women with ADHD across the life-
span, developed through a multidisciplinary consensus
meeting according to the clinical expertise and know-
ledge among attendees. To support medical and mental
health practitioners in their understanding of ADHD in
females, we provide consensus guidance on the presenta-
tion of ADHD in females and triggers for referral. We
establish specific advice regarding the assessment, inter-
ventions, and multi-agency liaison needs in girls and
women with ADHD.
In line with previous definitions, we use the terms sex
to identify a biological category (male/female), and gen-
der to define a social role and cultural-social properties
[37]. However, we acknowledge the complex differences
between the sexes that occur independently of ADHD
status [38], and discuss both biological differences and
social roles in the current consensus.
Methods
The consensus aimed to provide practical guidance to
professionals working with girls and women with
ADHD, drawing on the scientific literature and the pro-
fessional experience of the authors. To achieve this aim,
professionals specialising in ADHD convened in London
on 30th November 2018 for a meeting hosted by the
United Kingdom ADHD Partnership (UKAP; www.
UKADHD.com). Meeting attendees included experts in
ADHD across a range of mental health professions,
including healthcare specialists (nursing; general prac-
tice; child, adolescent and adult psychiatry; clinical and
forensic psychology; counselling), academic, educational
and occupational specialists. Service-users and ADHD
charity workers were also represented. Attendees en-
gaged in discussions throughout the day, with the aim of
reaching consensus.
The meeting commenced with presentations of pre-
liminary data obtained from (1) an ongoing systematic
review on the clinical and psychosocial presentation of
females in comparison with males with ADHD (cur-
rently being led by SY and OK); and (2) epidemiological
research on sex differences in self-reported ADHD
symptoms in population based adolescent cohorts. Fol-
lowing a question and answer session, attendees then
separated into three breakout groups. Each group was
tasked with providing practical solutions relevant to
their assigned topic. Discussions were facilitated by
group leaders and summarized by note-takers. Following
the small-group work, all attendees re-assembled. Group
leaders then presented findings to all meeting attendees
for another round of discussion and debate, until con-
sensus was reached. Group discussions included the fol-
lowing themes:
1. 1: Identification and assessment of ADHD in
females
1.1 Presentation in females and what might trigger
referral?
1.2 Considering sex differences when conducting
ADHD assessments




3. 3: Multi-agency liaison
3.1 Educational considerations
3.2 Other multi-agency considerations
Taking a lifespan perspective, each theme was ex-
plored in relation to specific age groups considered to be
associated with pertinent periods for environmental and
biological change, and change in clinical needs and pres-
entation. Recommendations that differed between age
groups are presented separately.
The consensus group incorporated evidence from a
broad range of sources. However, the assessment,
pharmacological treatment, and multiagency support
features reflect clinical practice and legislature in the
United Kingdom (UK), and may differ in other
countries.
All consensus proceedings, including group and feed-
back sessions were video-recorded and transcribed. One
note-taker was allocated to each breakout group, and
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notes were subsequently circulated to each breakout
group contributor for review and agreement. All mate-
rials were sent to the medical writer, who consolidated
the meeting transcription, electronic slide presentations
and small-group notes. The lead author worked closely
with the medical writer to synthesise the consensus re-
port, which was then circulated to all authors for review
and feedback. A final draft was circulated to all authors
for agreement and approval.
Results and consensus outcome
Presentation of ADHD in females
Although much of the scientific literature indicates an
overlap in the clinical presentation of males and females
with ADHD, the available evidence often draws on pre-
dominantly male samples [39] due to the higher preva-
lence of ADHD in males [4]. Some sex differences have
been reported, which are described below, and briefly
summarised in Table 1.
ADHD symptoms
Research in population-based samples indicates that for
both sexes the hyperactive-impulsive type predominates
in pre-schoolers, whereas the inattentive-type is the
most common presentation from mid-to-late childhood
and into adulthood [4, 21]. By contrast, clinical studies
typically report a greater prevalence of combined-type
ADHD [5, 12, 22]. Early meta-analyses of gender effects
have found lower severity of hyperactivity-impulsivity
[40], or all ADHD symptoms (inattention, hyperactivity,
impulsivity) [24] in girls than boys, although individual
studies show more mixed results [8, 35, 41, 42].
Inconsistent findings may reflect that clinic referral and
diagnosis tends to favour combined subtypes equally
across genders, whilst community sampling points to
greater prevalence of inattentive type ADHD in girls than
in boys [43]. Hyperactive-impulsive symptoms have been
linked to higher clinic ascertainment rates [4], and may be
more commonly seen in boys [40], with inattention symp-
toms being less obvious and therefore less likely to be de-
tected. These differences may lead to the perception that
females with ADHD are less impaired [44].
People may experience and respond to the same be-
haviour of males and females in different ways due to
gender-related behavioural expectations [42]. For ex-
ample in two studies where teachers were presented
with ADHD-like vignettes, when simply varying the
child’s name and pronouns used from male to female,
boys names were more likely to be referred for add-
itional support [45] and considered more suitable for
treatment [46]. Parents may also underestimate impair-
ment and severity of hyperactive/impulsive symptoms in
girls whilst over-rating these same symptoms in boys
[47]. Compensatory behaviours in girls, such as socially
Table 1 Summary of key points for detection of ADHD in
females
ADHD symptoms:
• Females present with both inattentive and hyperactive-impulsive
symptoms
• Symptom severity may be lower in females than in males, particularly
for hyperactive-impulsive symptoms.
• Inattention in girls and women with ADHD may present as being
easily distracted, disorganised, overwhelmed and lacking in effort or
motivation.
• Symptoms are pervasive and impairing rather than transient or
fluctuating.
• ADHD symptoms may become more obvious later in females, often
during periods of social or educational transition.
• Adult women may develop awareness of their difficulties leading
them to self-present to primary services.
• Symptoms may be exacerbated by hormonal changes during
menstrual cycle, pregnancy and menopause.
• Gender-based biases in teachers and parents appear to affect referral
likelihood.
• Less overt ADHD symptoms are less likely to lead to referral which
means that inattentive girls are more often missed.
Comorbidity:
• In girls and women with ADHD common comorbidities appear more
internalised in nature.
• Whilst externalising behaviours and conditions may present in
females with ADHD, these are less common than in males with ADHD.
• Females may suffer more general impairments in intellectual
functioning.
• Risk of substance use disorders is elevated for both males and
females with ADHD.
• Internalising symptoms secondary to, or comorbid with ADHD may
be misinterpreted as primary conditions. Low mood, emotional lability,
or anxiety may be especially common in females with ADHD.
• The key message is not to discount ADHD in females because they
do not display the behavioural problems commonly associated with
ADHD in males.
Associated features and vulnerabilities
• Difficulties with emotional lability and emotional dysregulation may
be more severe or common in girls and women with ADHD.
• Social problems may be particularly impairing.
• Girls with ADHD are vulnerable to bullying, including physical and
social-relational bullying, and cyberbullying.
• Females with ADHD tend to become sexually active earlier than their
peers and have an increased number of sexual partners. Rates of
contraction of sexually transmitted infections and rates of teenage, early
and unplanned pregnancies are elevated.
• Antisocial behaviour may also be present in females with ADHD. The
rate of ADHD among prisoners is similar for male and female offenders.
• Increased school dropout, academic under-achievement.
• Decreased self-esteem and self-concept
• Increased rate of accidents.
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adaptive behaviour, compliance, increased resilience [47]
or coping strategies to mask behaviour [48] may also
contribute to differing perceptions that may in turn pre-
vent referral.
Less is known about the presentation of ADHD in
older adults but evidence suggests whilst symptoms tend
to decline, ADHD may persist into middle and old age,
with a more even male-to-female community prevalence
and referral rate with increasing age [22, 49].
Comorbidity
Externalising problems are more prevalent in males with
ADHD [24], manifesting as higher rates of comorbid op-
positional defiant disorder (ODD) and conduct disorder
(CD) [40], characterised by rule-breaking behaviour [50,
51] and fights in school [36]. In adulthood, men with
ADHD more commonly show antisocial behaviours
characteristic of antisocial personality disorder [52–54].
Whilst these problems are more prevalent in males, they
typically remain elevated in individuals with ADHD
across both sexes in comparison with the general popu-
lation. The lower rates of disruptive behavioural prob-
lems in females may contribute to lower rates of referral
for ADHD assessment and support [48, 55].
Compared with males with ADHD, internalising disorders
(e.g. emotional problems, anxiety, depression) are more often
reported in females [24, 29, 47, 51, 53, 56]. Borderline per-
sonality traits in ADHD tend to be associated with women
[57] with hyperactive/impulsive symptoms being associated
with self-harming behaviours [58]. Additionally, women with
ADHD have been found to be at higher risk for some ad-
verse outcomes, including greater mental health impairment
[29], severe mental illness (schizophrenia) [59] and admis-
sions to in-patient psychiatric hospitals in adulthood [60].
The less overt presentation of ADHD in girls and
women may mask the underlying condition due to fe-
males not meeting stereotypical expectations of ADHD
behaviour. Instead females may be more likely to attract
a primary diagnosis of internalising disorders or person-
ality disorders, in turn delaying diagnosis and appropri-
ate treatment [45, 47, 48].
Disordered eating behaviour has been associated with
ADHD across both sexes. Whilst individual studies have
shown increased disordered eating in girls and women
with ADHD [53, 61], a meta-analysis of twelve studies
identified increased risk of all eating disorder syndromes
(bulimia nervosa, anorexia nervosa and binge eating dis-
order), amongst individuals with ADHD, with similar
risk estimates for males and females [62]. Meta-analysis
has also confirmed increased co-occurrence of obesity in
children and adults with ADHD [63, 64], albeit with no
difference between males and females.
Consensus meeting attendees highlighted the co-
occurrence of somatic symptoms such as pain and fa-
tigue with ADHD in females, based on clinical observa-
tion. There is little available research on sex differences
in the prevalence of somatic symptoms such as pain and
fatigue in people with ADHD. However, elevated ADHD
symptoms have been reported in clinical cohorts with
fibromyalgia [65], and chronic fatigue syndrome [66].
Young people with ADHD are at greater risk for to-
bacco and alcohol use in mid adolescence [67]. In adult-
hood they are more likely to become smokers [68],
engage in higher rates of substance use [69] and develop
alcohol and drug use disorders [70]. A prospective
follow-up study of a nationwide birth cohort using Da-
nish registry data reported that ADHD increased the risk
of all substance use disorder (SUD) outcomes [71], with
comparable risks seen for males and females. Females
with ADHD (but without any comorbid conditions) had
a higher risk of alcohol and cannabis abuse when com-
pared with males.
Associated features, functional problems and impairments
In both children and adults ADHD is commonly accom-
panied by emotional lability and emotion dysregulation
problems (irritability, low frustration tolerance, mood
changes) [72–74]. Difficulties of this nature may be more
common or severe in girls and women [30, 56–58] and
emotion dysregulation problems are associated with a
broad range of impairments in adulthood, including edu-
cational, occupational, social, familial, criminal, driving
and financial problems [75, 76]. In an Icelandic study of
ADHD symptoms in university students, poor social
functioning best predicted dissatisfaction with life in
males, whereas among females the best predictor of life
dissatisfaction was poor emotional control [77].
Cognitive problems are well established in ADHD
[78–80], spanning difficulties with executive dysfunction
(such as inhibition, planning, working memory and set
shifting) and non-executive cognitive domains (e.g. word
reading, reaction times, colour or letter naming, re-
sponse consistency). However, ADHD may also be asso-
ciated with general impairments in intellectual
functioning, which tends to be more prominent in fe-
males [24, 40]. Subtle social cognition deficits, including
facial and vocal emotion recognition, have also been
Table 1 Summary of key points for detection of ADHD in
females (Continued)
Compensatory and coping behaviours:
• Compensatory behaviours may mask behaviour and impairments,
and delay time to referral.
• Dysfunctional strategies, such as drinking alcohol or smoking cannabis
may be used to cope with emotional turmoil, social isolation and rejection.
• Some girls may seek to build social support through high risk
activities (e.g. joining a gang, promiscuity, criminal activities).
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reported in both males and females with ADHD, with
no clear sex-related differences [81].
A similar level of social impairment has been identified
for ADHD males and females [24, 40, 82]. Autistic-like
symptoms, including social and communication impair-
ments, are common in both girls and boys with ADHD,
and although these present at a higher rate in boys, likely
influenced by the higher base incidence of ASD in boys,
alongside greater difficulties in detecting ASD in girls [16]
Children with ADHD are more likely to experience re-
jection and unpopularity and have fewer friendships than
their peers [83] and social problems can persist into
adulthood [75]. Disruption to relationships with parents,
siblings and peers has been reported for females with
ADHD [84, 85]. Girls with ADHD may apply a range of
ineffective strategies to resolve their peer relationship
problems [86, 87], and experience more bullying than
their peers [88], including physical, social-relational, and
cyberbullying victimisation [23, 89, 90], whilst in boys
physical victimisation appears to be more common [91].
Peer victimisation has been associated with reduced self-
esteem and self-efficacy, and increased anxiety and de-
pression symptoms in young people with ADHD [90,
91]. Adverse outcomes have been associated with inter-
personal difficulties in females with ADHD including
lower satisfaction with romantic relationships [92] and
lower self esteem [48].
There is some evidence to suggest that elevated symp-
toms of ADHD are associated with excessive internet
use in children and adolescents [93], as well as adults
[94], but the causal direction of this association is un-
clear (i.e. elevated ADHD symptoms could trigger exces-
sive internet use, or excessive internet use could lead to
elevated symptoms of ADHD) [95]. Excessive gaming
[96] has also been reported. It is not clear whether this
association is stronger in males or females or if it is
equivalent across the sexes [93, 94, 97]. A large web-
based survey of adult internet behaviours and psycho-
pathology in Norway found that elevated ADHD symp-
toms were associated with increased addictive
technological behaviours, including social media use and
gaming [98]. Overall however, addictive social media use
was more common in women [98].
Throughout adolescence and the transition into adult-
hood, there is an increase in risk taking behaviour which
may be associated with symptoms of hyperactivity and/
or impulsivity [48]. For example, young people with
ADHD become sexually active earlier, have more sexual
partners and are more frequently treated for sexually
transmitted infections [99]. Rates of teenage, early or un-
planned pregnancies are elevated in girls and women
with ADHD [100–102]. Pregnant women with ADHD
are more likely to smoke up to the third trimester, or be
obese or underweight [102].
A review of ADHD and driving reported that adults
with a history of ADHD may be more likely to be unsafe
or reckless drivers and have more frequent or severe
crashes [103], albeit with no specific examination of sex
differences. One study with data from the US National
Epidemiologic Survey on Alcohol and Related Condi-
tions, showed that reckless driving was significantly
more frequent in men compared with women with
ADHD, reflecting the same pattern as seen the general
population [29]. This suggests that reckless driving is
likely to be similarly proportionally enhanced in women
as in men with ADHD.
Studies specifically reporting driving problems in
women with ADHD have shown no significant associ-
ation between ADHD and driving outcomes [68, 100,
104]. However, results from a prospective follow-up
study of a nationwide birth cohort in Danish registers,
reported increased mortality rate among individuals with
ADHD; when compared with males with ADHD, fe-
males with ADHD had an increased mortality rate after
controlling for comorbid CD, ODD and SUD [104]. The
excess mortality in ADHD was mainly driven by deaths
from unnatural causes, especially accidents. The authors
speculate that the gender difference may be driven by fe-
males being less likely to be diagnosed and receive treat-
ment than males with the disorder, leading to greater
risk of accidental death.
Delinquency and criminality in females with ADHD is
more common compared with their non-ADHD peers
but less severe or prevalent than reported in males with
ADHD [85, 105, 106]. A study examining adult criminal
outcomes in children with ADHD, showed males were
twice more likely to be convicted than females, but con-
victions in females occurred at eighteen times the rate
seen in the general population [106]. Prevalence of
ADHD in prison populations is estimated at 25%, with
no significant differences seen in relation to gender or
age [107].
Triggers for referral
There are multiple potential triggers that may prompt
the referral of females for assessment, shown in Table 2.
Some of these triggers are indicative of other associated
conditions and it is the clustering of multiple trait-like
symptoms that are pervasive and impairing that is in-
formative, rather than state-like symptoms showing situ-
ational change. The decision to refer would also be
strongly supported if there is a first-degree relative with
ADHD.
The stereotype of the ADHD ‘disruptive boy’ [47] is
likely to influence the likelihood of referral and access to
diagnosis and treatment. The key message is not to dis-
regard females because they do not present with the
externalising behavioural problems, or the disruptive,
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hard-to-manage presentation (e.g. engaging in boister-
ous, loud behaviours) commonly associated with males
with ADHD. Females with ADHD may be overlooked
and/or their symptoms misinterpreted, particularly for
those in highly structured environments, receiving a high
level of support, and for those who have developed strat-
egies to mask or compensate for their difficulties.
It is important to be mindful that environmental de-
mands (including educational, occupational, financial,
familial and social functions and responsibilities) in-
crease in number, scope and complexity with age and
level of independence, whilst support resources decline
[108]. Many young peoples’ struggles and impairments
become apparent as they lose the family and educational
scaffolding that was previously in place. Therefore,
young people (both males and females) may be particu-
larly vulnerable at times of transition, when symptoms
become exposed. Increased functional demands on
Table 2 Co-occurring functional problems, features or conditions commonly seen in girls and women with ADHD
Legend: Co-occurring functional problems, associated features or conditions commonly seen in addition to ADHD symptoms in girls and women with ADHD,
presented along with age-ranges for detection. These may serve as triggers to help to identify individuals who may require assessment for ADHD
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transition to secondary school (planning ahead, organis-
ing work and juggling assignments) may lead them to
feel overwhelmed. This may impact on self-esteem and
result in learner anxiety and perfectionism in an attempt
to compensate. Periods of transition may therefore un-
mask unidentified ADHD by exposing or exacerbating
symptoms, together with the development of internalis-
ing problems leading to increased vulnerability.
These environmental changes often occur at a time
when girls undergo changes in their physiological and
sexual maturation. There is growing recognition that pu-
berty is a phase of high risk for mental health problems
[109]. The developmental changes that occur during pu-
berty and later in adolescence may lead females with
ADHD to be particularly psychologically vulnerable if
they are not able to access support.
Difficulty coping with more complex social interac-
tions and resolving interpersonal conflict may also trig-
ger cause for concern. As girls with ADHD move into
their teenage years, difficulty maintaining friendships
often becomes more marked and they may feel rejected
and socially isolated. Some respond with bravado to buf-
fer them from social isolation but a ‘brave face’ is un-
likely to prevent them from feeling distressed and
developing low mood and anxiety. Dysfunctional coping
strategies and the lack of a support network may lead
them to express these feelings by self-harming behav-
iours (e.g. cutting) or changes in eating patterns.
The identification of specific educational or learning
problems may also be an important trigger for referral.
Children may be diagnosed with specific learning diffi-
culties, such as dyslexia, when a diagnosis of ADHD may
be more appropriate. Parents/carers and teachers may
note the disparity between educational performance
(day-to-day classroom contribution) and achievement
(end grades).
Many young people with ADHD do not exceed the
mandatory minimum level of schooling, and the prob-
lems described above may become even more marked
when they enter further education and/or leave home.
Research suggests that adolescent school girls with ele-
vated ADHD symptoms make significantly fewer plans
for their future than their peers, suggesting that they
leave this to chance and opportunistic encounters [86].
Those who enter the world of work may find that their
difficulties evolve into employment impairments and
limitations. However, as they mature young people may
begin to develop greater awareness of their difficulties,
leading to an increase in self-referrals.
Assessment
For both males and females, a comprehensive assess-
ment should be completed to accurately capture the
symptoms of ADHD across multiple settings, their
persistence over time and associated functional impair-
ments. High rates of comorbidity are typically present.
The assessment process is typically tripartite involving
the use of rating scales, a clinical interview and ideally
objective information from informants or school reports.
Key recommendations for enhancing diagnostic assess-
ment in girls and women are provided in Table 3.
Rating Scales
Rating scales can obtain perspectives from different in-
formants (e.g. family, teacher, youth worker, occupa-
tional health practitioner) in a consistent, quick and easy
way. They are not the sole domain of healthcare practi-
tioners and can be applied (with patient consent) by al-
lied professionals, such as social care providers and
those working in educational and occupational establish-
ments, to guide whether referral might be merited.
While rating scales are useful aids for clinical assess-
ment and treatment monitoring, findings should be
interpreted cautiously if they are used for screening pur-
poses as they are non-specific markers of potential prob-
lems [110]. Rigid adherence to cut-offs may lead to a
high proportion of false positives and negatives. There
are many rating scales available with varying merits and
limitations and some are yet to be updated to reflect re-
visions to diagnostic criteria. Where possible both in-
formant- and patient-rated scales should be obtained.
Rating scales in common use are presented in Table 4.
Rating scale norms are predominantly from male or
mixed samples, which may disadvantage their use in fe-
males, although some provide female-specific norms (see
Table 4). Where female norms are not available, greater
emphasis should be placed on collateral information
(e.g. parental and school reports). The Nadeau and
Quinn checklists may also be used as indication of pos-
sible ADHD in girls and women [126, 127], providing
structured self-enquiry of ADHD symptoms and associ-
ated problems, including a range of difficulties such as
learning problems, social/interpersonal and behavioural
problems.
Since hyperactive and impulsive behaviours tend to
decline as patients move into adulthood and impair-
ments associated with inattention are often sustained, it
is helpful to re-administer age appropriate scales as
young people with ADHD become adults.
The clinical interview
A clinical diagnostic interview, supplemented by a men-
tal state examination, should consider the extent to
which the individual’s functioning is age appropriate and
obtain examples of how difficulties interfere with func-
tioning and development in home and education/work
environments. For children this is usually carried out in
the presence of a person close to the child, has known
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the child for a long time, and is familiar with their devel-
opmental history and functioning in different settings
(commonly a parent or carer).
Age-appropriate, common co-occurring conditions in
females with ADHD should be explored, including ASD,
tics, mood disorders, anxiety, and eating disorders. Fibro-
myalgia, chronic fatigue syndrome, body dysmorphic dis-
order and gender dysphoria may also be explored as
possible co-occurring conditions. The assessor needs to
consider what is primary (i.e. occurring alongside and in-
dependently to ADHD) and what is secondary (i.e. caused
or exacerbated by ADHD). It will help to determine
whether the presenting problem is trait-like or episodic in
nature. Clinicians should be alert to signs of self-harming
behaviours (especially cutting), which typically peak in
adolescence and early adulthood [128, 129]. Substance
and alcohol use disorders should also be assessed in teen-
agers and adults. Sleep problems are commonly seen in
both males and females with ADHD [130, 131], and it is
important to determine whether this primarily relates to
symptoms of ADHD or co-occurring anxiety.
Since heritability of ADHD is high, ranging between
70-80% in both children and adults [132], it is important
to be mindful that informants who are family members
may also have ADHD (possibly undiagnosed) which may
affect their judgment of ‘typical’ behaviour. The assessor
should therefore obtain specific examples of behaviour
from the informant and use these to make clinically in-
formed judgments, rather than relying upon the infor-
mants’ perception of what is typical or atypical.
Semi-structured clinical diagnostic interviews are
helpful as they guide the healthcare practitioner to
complete a comprehensive developmental and clinical
interview, whilst allowing for individual differences to
be considered. For example, symptoms relating to ex-
cessive talking, blurting out answers, fidgeting, inter-
rupting and/or intruding on others have been
reported as more frequently endorsed by women than
men with ADHD [53, 55] and may be more sensitive
to the presentation in females. Small modifications
may help to capture more female-centric behaviour
(e.g. ‘excessive talking and giggling’ instead of ‘exces-
sive talking’) [133]. Commonly used diagnostic inter-
views are presented in Table 4. There are three
clinical interviews that prompt the assessor to con-
sider the presence of co-existing conditions (which
may differ between males and females); ACE, ACE+
[134] and the DAWBA [118].
When assessing adults, the clinical interview is usually
completed with the affected individual but whenever
possible collateral information should also be obtained.
This may be from a parent or carer or another close
member of the family. If a reliable informant cannot be
identified who knew (and can recall) the individual well
during their childhood, it may be helpful to obtain infor-
mation from an informant who currently knows the in-
dividual well (e.g. a partner or a close friend who has
known them for a significant period time, 5 years or
more) in order to supplement self-reported information
with a secondary perspective. If available, reports from
childhood (for example, school, social service and/or
previous clinical reports) are likely to be informative.
Importantly, however, it may not be possible to rely on
school reports when assessing females, as subtle
hyperactive-impulsive symptoms may have been missed
by teachers and/or they omit to comment on interper-
sonal or relationship problems. School reports may com-
ment more on attentional problems (such as
daydreaming or lacking in motivation and effort).
Some girls and women with ADHD become compe-
tent at camouflaging their struggles with compensatory
strategies, which may lead to an underestimation of their
underlying problems. Often these strategies have an
adaptive or functional purpose, for example, enabling
them to remain focused or sustain attention, or to
Table 3 Enhancing ADHD diagnostic assessment in females:
consensus recommendations
Rating scales, a clinical interview and an observational assessment.
Rating scales
• Norms from predominantly male or mixed-sex samples may disad-
vantage female patients. Rating scales providing female norms (see
Table 4) may provide cut-offs more sensitive to female presentation.
• Where female norms are not available, greater emphasis on collateral
information is required (e.g. parental and school reports).
• Findings should be interpreted cautiously. Rigid adherence to cut-offs
may lead to a high proportion of false positives and negatives.
Clinical interview
• Assessors should bear in mind that family members may also have
ADHD which may affect their judgment of ‘typical’ behaviour.
• Small modifications to symptoms may help to capture more female-
centric behaviour (see topic for examples).
• Assessors should examine factors that may mask or moderate
behaviour in different settings, e.g. compensatory strategies or
accommodations at home or school (both functional and dysfunctional).
• Age-appropriate, common co-occurring conditions in females with
ADHD should be explored, including ASD, tics, mood disorders, anxiety,
eating disorders, fibromyalgia and chronic fatigue syndrome.
• A risk assessment and consideration of future challenges (e.g. personal,
clinical, educational, social-relational and psychosexual) is required.
Collateral information
• School reports may comment more on attentional problems
(daydreaming, distracted, disorganised, lacking in motivation and effort)
or interpersonal relationship problems in girls with ADHD.
• Objective neuropsychological test results are not specific markers of
ADHD but may provide useful supplementary clinical information. The
QB scales have female-specific normative data and may therefore be
more sensitive.
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disguise stress and distress. However, not all strategies
are helpful. Coping strategies may be less overt, such as
avoiding specific events, settings or people, not facing up
to problems, spending too much time online or not
seeking out help when needed. Teenage and adult fe-
males with ADHD may turn to alcohol, cannabis and
other substances to manage emotional turmoil, social
isolation and rejection. Some may seek to obtain a social
network by forming damaging relationships (for
example, joining a gang, engaging in promiscuous and
unsafe sexual practices, or criminal activities). If there is
cause for concern, a risk assessment should be included
that enquires into suicidal ideation, the use of illicit
drugs, substances and alcohol, antisocial attitudes and
behaviours, harm to self and others, bullying and assault,
excessive internet use, unsafe sexual practices and ex-
ploitation of a sexual, financial or social nature. In some
cases, a physical health assessment may be warranted.
Table 4 Clinical assessment resources which are in common use for ADHD
Rating scales










SNAP-IV R Rating Scale [112] 8-18 • Parent rated
• Teacher rated
No Yes
RATE-C [113] 8-11 • Patient-rated
• Informant rated
No Yes
Kiddie-SADS DSM-5 Screen Interview (K-SADS-PL) [114, 115] 6-18 • Patient rated
• Parent rated
No Yes





The Vanderbilt ADHD rating Scales (VARS) [117] 6-12 • Parent rated
• Teacher rated
No Yes
The Development and Well-being Assessment (DAWBA) [118] 2-17 • Teacher rated No No
RATE [113] 16-54 • Patient-rated
• Informant rated
No Yes
Conners’ Adult Rating Scales (CAARS) [119] 18+ • Patient-rated
Informant rated
Yes No
Adult ADHD Self-report Rating Scale (ASRS) [120] 18+ • Patient-rated No Yes
Clinical interviews




ADHD Child Evaluation (ACE) [121] 5-16 Administered to informant (parent,
carer, family member) close to patient.
Patient also typically invited to
contribute.
Yes
The Development and Well-being Assessment (DAWBA) [118] 5-17 Administered separately to patient (if
age 11-17 years) and parent/carer
No
Young DIVA-5 [122] 5-17 Administered to patient in the
presence of a parent, carer or family
member (where possible)
No
ACE+ [123] 16+ Ideally administered to patient in the
presence of an informant
Yes
Conners’ Adult ADHD Diagnostic Interview for DSM-IVTM [124] 18+ Administered to patient No
Diagnostic Interview of Adult ADHD (DIVA-5) [125] Limits not
specified
Administered to patient No




Administered to patient with
intellectual disability in the presence of
an informant/carer (where possible)
No
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With older age and persistent inattentive symptoms,
there may be an increasing risk that individuals with
ADHD are incorrectly diagnosed with mild cognitive im-
pairment. Self- perceived ADHD symptoms, and in par-
ticular inattention, are found to increase with age in
diagnosed adults and perceived symptom severity ap-
pears to be exacerbated by concurrent depressive symp-
toms [49]. It is not uncommon that adults with ADHD
are treated for anxiety and/or depression in the first in-
stance. Clinicians should be mindful that those with
treatment resistant anxiety and/or depression should be
screened for possible undiagnosed ADHD. Indeed, care-
ful examination of developmental history will elucidate
whether symptoms are longstanding and have been ex-
acerbated by situational or biological changes, or
whether they represent new-onset symptoms that are
less indicative of ADHD.
Objective assessments
Whenever possible, the assessor should obtain collateral
information from independent sources. This may include
direct observations in a specific setting (e.g. in clinic, at
home or at school). A wealth of useful information may
be obtained from observing a child in school and speak-
ing directly with teachers. When assessing adults, per-
usal of school, college and/or employment reports (if
available) can be helpful.
Tests that assess executive dysfunction may help to deter-
mine deficits in higher order processing skills such as task
switching, perseveration, planning, sequencing and organis-
ing information. Some have been specifically developed for
ADHD populations and focus on assessing attention, impul-
sivity and vigilance in children and adults. Neuropsycho-
logical tests such as the Test of Everyday Attention (TEA) /
Test of Everyday Attention for Children (TEACh), may be
helpful supplements to the diagnostic process. Those most
commonly used in clinical practice include the Conners’
Continuous Performance Test, third edition (CPT 3 [age
8+]) [135] and the QbTest [136], the latter including a meas-
ure of hyperactivity. QbTest scales have normative data spe-
cific to each sex (age 6-60) and may therefore be more
sensitive to ADHD in females. The assessor should be mind-
ful that an individual with ADHD may perform relatively
well on novel tasks, especially those presented as compu-
terised games providing immediate gratification via rapid
feedback. Moreover, findings may lack ecological validity and
not reflect performance in the ‘real world’. Neuropsycho-
logical assessments are not specific markers of ADHD and
should only be used to augment clinical decision making
and not be used as stand-alone diagnostic tools.
Interventions and Treatments
Prompt identification and treatment of ADHD is recom-
mended, as there is evidence of long-term functional
benefits associated with treatment [137, 138]. ADHD is
typically treated with psychoactive medication, psychoe-
ducation and therapeutic interventions at all ages, and a
stronger treatment effect has been reported with multi-
modal treatment [138]. A brief summary of treatment
recommendations is presented in Table 5.
In the context of changes in the presentation of
ADHD with development and ageing, regular treatment
reviews are advised. These can revisit and optimise
current pharmacological and non-pharmacological ap-
proaches, or revisit those patients who previously may
not have been suitable for specific treatments or who
did not show good response.
Pharmacological management
ADHD is commonly treated with psychostimulants,
such as methylphenidate and amphetamine. In certain
cases, a nonstimulant such as atomoxetine, an
extended-release form of guanfacine or clonidine, or
bupropion may be prescribed, especially when stimu-
lants are inappropriate or have been unsuccessful.
These medications, with the exception of bupropion
are recommended by the National Institute of Health
and Care Excellence (NICE) guidance [139]. A system-
atic review and network meta-analysis recommended
methylphenidate for children and adolescents and am-
phetamines for adults, taking into account both efficacy
and safety [140]. Larger confidence intervals in relation
to the tolerability and efficacy of bupropion, clonidine
and guanfacine were reported, indicating less conclu-
sive results with regards to the efficacy and tolerability
of these oral medications [140].
Treatment recommendations do not differ by sex and
differ only modestly by age (NICE, 2018 [139]). The
overarching opinion in the consensus group was that
there are no differences in the medicines used to treat
ADHD in girls and boys. Stimulant medications show
good efficacy for improving ADHD symptoms in both
children [141] and adults [142], and response appears
comparable in females and males [143, 144]. However
girls with ADHD tend to be less likely to be prescribed
stimulant treatment than boys with ADHD, and are
likely to start treatment at an older age [145].
The potential benefits of treatment must be viewed in
the context of lifetime adverse outcomes associated with
poorly managed ADHD described previously. Prompt
identification and treatment may help to improve
longer-term functional, health and mental health out-
comes. Reduced rates of comorbidity (including depres-
sion, anxiety disorders, and disruptive behaviour
disorders) have been noted in stimulant treated ADHD
populations [146, 147], although the converse effect has
also been reported [148]. Comorbid ADHD is associated
with treatment resistant depression [149] and regular
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treatment for ADHD may reduce rates of treatment re-
sistance [150]. Pharmacological treatment of ADHD is
also associated with improved educational [146] and oc-
cupational [151] outcomes, as well reduced rates of
criminality [152]. Pharmacotherapy for ADHD appears
to be a protective factor for obesity [64], and some lim-
ited evidence suggests that it may increase efficacy of
weight management strategies (reviewed in [153]). Add-
itionally, there appears to be a benefit of ADHD treat-
ment with regards to substance use disorders. A study of
commercial healthcare claims showed reduced emer-
gency department visits related to substance use disor-
ders when patients were prescribed treatment for
ADHD [154].
Whilst pharmacological treatments themselves should
not differ by sex, the way in which they are managed
and monitored should occur in a sex-sensitive manner.
The consensus group observed that prescribers need to
consider ADHD presentations and associated problems
in females to appropriately target what medication aims
to improve. It may be less helpful to strictly adhere to
conventional rating scales or focus on behaviour man-
agement to identify treatment-related changes. Instead,
treatment response may be better captured through
individualised targets, such as measures of emotional
regulation, participation in education, and academic at-
tainment. In the UK, all government funded schools
have attainment ratings for each child, which could be
examined by the prescriber prior to commencement of
medications and monitored over time in conjunction
with prescribing. Girls with emotional regulation diffi-
culties (for whom internalising difficulties are often a
key component of their ADHD) could benefit from
measuring changes in emotional lability with medica-
tion use.
Parents and carers may not be as aware of the benefits of
medication in girls, especially those with inattentive presen-
tations in the absence of challenging or disruptive behav-
iour. Psychoeducation regarding available treatments and
what they are targeting, provided for parents and girls with
ADHD themselves, may help to ensure engagement in
treatment and improve adherence to treatment regimens.
Where required, adherence may be improved by using
long-acting stimulant medication in place of short-acting
medications [155–157].
In early to late adolescence, recommended treatment
regimens in ADHD remain the same as in early child-
hood, and do not differ between girls and boys. The use
of medication should be followed up over time to verify
if medications are effective and well tolerated, and to
manage the effects of related conditions (e.g. anxiety, de-
pression) if they emerge. Side effects of stimulants need
to be considered, particularly the side effect of appetite
suppression if eating disorders are a concern [158].
There is some early evidence to suggest that ADHD
medications may differentially affect women depending
on progression of their menstrual cycle. Two small stud-
ies have shown that hormonal changes during the men-
strual cycle (oestrogen and progesterone levels) may
impact on the subjective euphoric and stimulating ef-
fects of d-amphetamine in healthy women who are not
Table 5 Treating ADHD in girls and women: key consensus
recommendations
Pharmacological treatment
• Medication recommendations do not differ by sex and differ only
modestly by age.
• Treatment monitoring may require deviation from conventional
outcomes from rating scales and behaviour management. Individualised
targets (e.g. emotional lability, academic attainment) may be more
appropriate.
• Prescribing needs to consider interactions between ADHD and other
medications for comorbid conditions, where applicable.
• Where mood problems are apparent but not pervasive it is advisable
to treat ADHD symptoms and monitor for improvement first, prior to
considering or initiating treatment for mood disorders.
• Appetite suppression as a side effect of stimulant medication should
be considered if eating disorders are a concern.
• Risks of substance use whilst on ADHD medications should be
considered and discussed with patients.
• Treatment with ADHD medications is generally not advised during
pregnancy or breastfeeding.
• Review is advised during and after key periods of hormonal change
(menopause, pregnancy).
• Psychoeducation on pharmacological treatment options and
treatment targets for parents and affected girls may help to improve
adherence and engagement.
• Regular review is required throughout development and may be
especially important at times of key transitions.
Non-pharmacological treatment
• Whenever possible, provide psychoeducation taking a lifespan
approach.
• Parents and carers of teenage girls need psychoeducation to support
detection of deliberate self-harming or risky behaviour.
• Follow-up sessions are essential for support at key points of transition.
• Interventions should be tailored to needs and address difficulties and
challenges faced at home, school/work and in social activities.
• Both group and individual assessments may be beneficial.
• Direct parental input into interventions is required for
children. Adolescents and adults are more likely to receive direct
interventions without parental/carer input.
• Programmes for all ages will benefit from focus on ADHD symptoms
and associated problems, including executive functions, emotion
regulation, conduct and social impairments, in an age-sensitive manner.
• Programmes should differ depending on age with issues relating to
transition,
• As relevant, risk (sexual risk, substance misuse), and self-management
should be addressed in adolescence, with adult interventions including
employment problems, child-rearing and parenting.
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affected by ADHD [159, 160]. Changes in subjective rat-
ings of stimulation have also been noted in young
women unaffected by ADHD in response to d-
amphetamine after application of estradiol patches
(commonly used to treat problems associated with
menopause) [161]. Cellular and small neuroimaging
studies which show early evidence of a link between
dopamine systems (implicated in the aetiology of
ADHD) and gonadal hormones (reviewed in 49). In a
case study, a woman with ADHD showed positive re-
sponse to treatment adjustment around the menstrual
cycle, which included augmentation with an antidepres-
sant (fluoxetine) during the immediate pre-menstrual
period to reduce problems with moodiness, irritability
and inattention normally well controlled through stimu-
lant medication alone [162].
Whilst the evidence above does not support treatment
adjustment according to the menstrual cycle, anecdotal
clinical accounts were given during the consensus meet-
ing supporting that this approach benefits certain pa-
tients. The consensus group noted that this type of
regular medication adjustment may be easier to manage
for adult women who can take more control of their
dosing, rather than adolescent girls who tend to respond
better to routine. There were also anecdotal accounts of
symptom exacerbation in women during the post-
menopausal period. During this time physicians may
consider the use of hormone replacement therapy, if
deemed beneficial.
As hormonal changes take place during puberty, the
postpartum period and the menopause, patients may re-
port changes in their symptoms and re-evaluation of
treatment regimens may be helpful. It may be advised
that women track their symptoms during these periods
to establish patterns which may help support changes to
the medication regimen when reviewed by their
physician.
There is no evidence to indicate that females in either
early, middle or later adulthood should be treated any
differently with respect to specific medicines for ADHD
symptoms. However, given the complex clinical picture
of many adults with ADHD, particularly with regards to
the presence of comorbid conditions, prescribers need to
be mindful of potential interactions with other drugs. If
ADHD treatment improves co-morbid conditions, medi-
cation regimens could potentially be simplified.
Women with ADHD are highly likely to suffer from
mental illness and SUDs. Clinicians need to be mindful
of, and discuss with their patients, the risks around alco-
hol and drug use whilst on ADHD medications.
Affective symptoms (most commonly emotional lability
or volatility) associated with ADHD, may be misattribu-
ted to depressive disorders. For women with ADHD in
whom depressive mood symptoms are apparent but not
pervasive, it is advisable to treat the ADHD symptoms
first and monitor for improvement. A more consistent
low mood may be due to demoralization driven by
ADHD and its functional impairments, and may improve
with ADHD medication.
Symptoms or problems experienced by women with
ADHD may also overlap with those indicating a person-
ality disorder, such as BPD. Careful consideration is re-
quired to establish the underlying condition(s). This will
have follow-on implications for treatments, which differ
significantly between personality disorders and ADHD.
Biosocial theory suggests that BPD may arise as a func-
tion of the interaction of early vulnerabilities (impulsivity
and heightened emotional sensitivity) with the environ-
ment [163]. If ADHD symptomatology may predispose
individuals to later personality disorders [164], it is pos-
sible that early detection and appropriate treatment
could prevent the later development of these conditions
[165]. However, there is no clear empirical evidence sup-
porting this hypothesis at present [109].
Historically, prescribing ADHD medication during
pregnancy or breastfeeding was not advised due to a lack
of evidence for safety and risks of unknown adverse ef-
fects to the baby. However, a recently published system-
atic review and meta-analysis reported that exposure to
ADHD medication during pregnancy does not appear to
be associated with serious adverse maternal or neonatal
outcomes [166]. Nevertheless, the group were cautious
regarding this outcome and considered that until these
findings have been robustly replicated, prescribing
ADHD medication during pregnancy or breastfeeding
should be avoided. There may be situations however
where risks of not treating ADHD may outweigh poten-
tial risks to the foetus and continued prescribing may be
necessary subject to more careful obstetric monitoring.
In this case, women with ADHD need to be informed of
these risks.
Women may find their ADHD symptoms worsen or
become particularly difficult to manage while breastfeed-
ing given additional life pressures that occur in the pres-
ence of a new baby. Whilst it may be possible to use
short acting stimulant medication, timed around breast-
feeding to minimise transfer between mother and child
[167], there is minimal scientific evidence to support this
approach, and it would be generally safer to advise the
cessation of medications during this period altogether.
Where ADHD medication is necessary, then an alterna-
tive to breastfeeding is needed to minimise any risk to
the baby.
Prescribers should be aware that mothers with ADHD
may experience difficulties in managing their own symp-
toms alongside the increased demands from family life,
and these difficulties may be augmented by the presence
of ADHD in their own children. They may benefit from
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more frequent evaluations of ancillary support require-
ments and/or a careful review of medication dosage.
Non-pharmacological management
A number of meta-analyses of data from child and ado-
lescent samples have shown that non-pharmacological
interventions targeting cognitive processes show small to
moderate effects on ADHD symptom outcomes when
rated by individuals who are close to the treatment set-
ting (often parents), but that effects become attenuated
or non-significant when outcomes are obtained from in-
dividuals who are blinded to the interventions (often
teachers) or adequately controlled active or sham condi-
tions [168–170]. Research has documented this effect for
specific interventions such as cognitive training (for ex-
ample, training of attention, memory, inhibitory func-
tions) [169], and neurofeedback [170] - although more
recent research suggests that effects of neurofeedback
are more modest rather than absent when assessed by
probably blinded evaluators [171].
Meta-analyses also show potentially more promising
outcomes from non-pharmacological interventions that
target behaviours and outcomes beyond ADHD symp-
toms alone in children and adolescents, with ADHD
intervention in children producing a moderate effect on
parent stress [172], and organisational skills interven-
tions which resulted improved ratings from both parents
and teachers and with modest improvement in academic
function [173]. Behavioural interventions were found to
have a moderate positive effects on a range of outcomes
including changes in parenting and conduct problems,
even when rated by blinded assessors [174].
Meta analyses also indicate more promising results from
cognitive behavioural therapy, and mindfulness interven-
tions on ADHD symptoms in studies with primarily adult
samples, albeit without comparisons from blinded raters
[175, 176]. Benefits of non-pharmacological treatments in
adults are also shown to range beyond improvements in
ADHD symptoms, as shown in a recent report from a psy-
chological intervention programme in adults with high
levels of ADHD symptoms across three municipalities in
Denmark. Participant outcomes were compared with
matched controls receiving ‘treatment as usual’ drawn
from the Danish Registers at 6 and 12 months post-
treatment follow-up. The study showed that participation
in the programme was associated with increased employ-
ment, education rates and reduced use of cash benefits
and social services [177]
The efficacy of a psychological approach varies across the
lifespan and the content of treatment should be tailored to
meet the individual presentations and needs of individuals
with ADHD [178]. Regular review of how a person is cop-
ing may be especially important at times of key transitions.
Since the needs of females with ADHD differ considerably
as they mature, the goals of treatment are presented across
three age ranges: primary age (5-11 years), secondary age
(12-18 years) and adulthood (age 18+).
Primary age ADHD often places a significant psycho-
logical, emotional, and economic burden on families as
well as the individual; increased stress and discord in the
family unit has been reported [179, 180]. Where ADHD
affects females, it is also more common in their family
members [33, 34], resulting in bidirectional effects of
ADHD in the mother-child relationship. The aim of
non-pharmacological interventions therefore is to sup-
port individuals with ADHD and their families to de-
velop and/or improve skills and coping strategies.
Psychoeducation and psychological interventions di-
rected at both patient and family are needed to achieve
this, as they provide the tools to make helpful changes
and achieve positive immediate and long-term functional
outcomes.
There are two types of parenting intervention that
may be offered to parents/carers in this age-group: (1)
parent/carer support interventions, where people can
meet and share experiences with others, and (2) parent/
carer mediated interventions, sometimes referred to as
‘parent training’. The latter is an indirect intervention as
the parent/carer is taught to deliver interventions to
their child. Ideally both approaches should integrate a
psychoeducational component as this is likely to lead to
better outcomes.
Psychoeducation and interventions for girls in this
age group should include discussion about the diffi-
culties and challenges they will face at home, in
school and in social activities - and how they may re-
spond. At school this may relate to difficulty with
sustaining attention, organisation, time management,
planning activities, prioritising and organising tasks.
They may also require generic skills for coping with
interpersonal difficulties and/or social events, conflict
management, emotional lability, anxiety and feelings
of distress. Some girls may need interventions to ad-
dress discrete problems, including sleep problems
[131], enuresis [181], bullying [89, 90] and repetitive
behaviours such as nail biting [182]. It is important
to emphasise that problems may be less overt in fe-
males with ADHD compared with boys due to them
being less boisterous and hyperactive, yet their strug-
gles with impulse control may manifest in a different
way such as blurting out hurtful things to friends and
family in anger, or deliberately self-harming
behaviours.
Both group and individual sessions working directly
with the child may be helpful additions to parent/carer
mediated treatments, although individual treatments
may be more appropriate for those with severe
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symptoms, intellectual limitations and/or those who are
unable to tolerate group sessions (e.g. due to lack of
confidence, poor social communication). Two specific
programmes have been developed for young children
with cognitive, emotional, social and/or behavioural
problems; one for individual delivery [183] and the other
for group delivery [184, 185].
Secondary age As children mature, they are more likely
to receive direct interventions without input from their
parents or carers. The best mode of psychological treat-
ment is cognitive behavioural therapy (CBT) together
with psychoeducation (which can be provided to both
patients and parent/carers together or independently).
Parents and carers need to be aware of the elevated risk
of deliberate self-harming behaviour (e.g. cutting), eating
disorders, substance abuse, risk-taking behaviours, and
vulnerability to exploitation in teenage girls with ADHD.
Thus psychoeducation should include indicators that
problems of this nature may be developing.
The focus of treatment in this age group should in-
clude information and guidance on the need for adher-
ence to medication. There is evidence that adherence to
pharmacotherapy declines in the teenage years, although
adherence appears to be modestly better in girls than in
boys [155, 157, 186]. These changes have been attributed
to adverse effects, sub-optimal response, reduction in
parent supervision, increased need for autonomy, and
social stigma associated with ADHD diagnosis and tak-
ing medication [155, 156]. It is important to provide psy-
choeducation to encourage young people with ADHD to
understand and take ownership of their diagnosis and
treatment, rather than feeling it has been imposed on
them. Those diagnosed with ADHD for the first time in
their teenage years are likely to require different inter-
vention strategies to those who have been treated
pharmacologically earlier in childhood. For example,
psychoeducation should include information on the pur-
poses and benefits of particular medications, as well as
strategies around self-management.
Problems presenting in younger childhood often be-
come more marked with age due to increasing academic
and social expectations. These are important years in
terms of a young person’s education and interventions
can help to support executive function (e.g. improving
skills to address problems with time management, focus,
sustaining attention, organisation and planning) which
may in turn support their coping in secondary schooling.
Teenage girls may particularly benefit from treatment
aimed at improving self-concept and identity. This may
be achieved by unpacking the association between
ADHD, lack of achievement, poor self-efficacy, lack of
self-confidence, poor self-image and low self-esteem.
Aside from addressing core ADHD symptoms and ex-
ecutive deficits, specific interventions should focus on
developing skills and coping strategies for co-occurring
conditions, such as managing poor emotional regulation,
low mood and anxiety, controlling the impulse to delib-
erately self-harm (including skin picking and cutting),
eating for pleasure or restricting food. Additional sup-
port for new skills required in teenage years, such as
managing money, may also be helpful.
In adolescence, young people develop a strong focus
on peer relationships and a tendency towards social con-
formity [187]. For teenage girls with ADHD, the desire
to develop robust and supportive social networks can be
strong, and the rejection and social isolation experienced
by many may mean that family support is especially val-
ued [87]. Simultaneously interpersonal conflict with fam-
ily members is not uncommon, and girls may engage
with dysfunctional social groups and activities in an at-
tempt to gain a sense of ‘belonging’ and to be accepted.
Girls with ADHD are at increased risk of being victims
of bullying [23, 90], and social media may provide add-
itional challenges since it offers a public platform for
victimisation.
Behavioural and oppositional problems remain ele-
vated in teenage girls with ADHD in comparison with
their peers, albeit not as elevated as in boys with ADHD.
Girls with ADHD may attract detentions, suspensions or
exclusions from school for their conduct or oppositional
behaviour. Their behaviours may be more socially moti-
vated (e.g. spiteful, manipulative, threatening behaviours
and/or lashing out at peers) rather than overt aggression.
Social skills and interpersonal relationship interventions
become salient at this age. These may aim to develop
coping strategies to regulate emotions, build confidence,
raise self-esteem and manage peer pressure, deal with re-
jection and manage conflict.
Interventions to address impulsivity and associated
risk-taking behaviour may be helpful. These problems
may manifest in early onset of sexual behaviour. The
desire to be accepted into a peer network may be a
motivating factor. Girls with ADHD are more likely
to be pressurised into sex or engage in risky sexual
behaviour. They are also more vulnerable to sexual
exploitation or perceived exhibitionism (including
internet grooming, ‘sexting’ and posting inappropriate
content [188]). This may result in disproportionate
social stigma for adolescents and young women with
ADHD, in the face of violations of social expectations
of female sexuality (where promiscuity may enhance
male but damage female reputations). As girls become
sexually active, the need for contraception should be
discussed.
Impulsive behaviour is also associated with substance
misuse. The risks around substance use and interactions
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with ADHD medication, including risks for addiction,
need to be discussed.
Considerations around pregnancy, the post-partum
period and parenting may also be required, since rates of
early pregnancy are higher in girls with ADHD. Early
pregnancy, may load additional stress and impairment
on young girls with ADHD. The consensus group noted
difficulties in young ADHD mothers not only in relation
to child discipline and behaviour management, but also
in relation to the organisational demands of parenting
(for example, ensuring bottles are washed, medical and
other appointments are kept, child’s clothes are cleaned).
Both individual and group CBT interventions will be
helpful in this age-group, the latter providing the oppor-
tunity to meet and talk to others who have similar expe-
riences as well as acquire and rehearse social skills in a
contained environment.
Adulthood Many of the functional problems experi-
enced by women with ADHD in relation to educational,
social, and risk-related behaviours are a continuation of
those present in their teenage years. In adulthood, psy-
choeducation and CBT interventions should continue to
address core ADHD symptoms, executive dysfunction,
comorbid conditions and dysfunctional strategies (e.g.
substance abuse, deliberate self-harm). However, specific
attention may be required to address the more complex
situations adult females may face, e.g. multitasking occu-
pational demands, home management and family/par-
enting responsibilities. It is important to encourage the
patient to identify and focus on their strengths and posi-
tive attributes rather than solely on perceived weak-
nesses and failures.
Interventions need to address the potential for women
with ADHD to be vulnerable in terms of their sexual be-
haviour and relationships, to support their sexual health
and safety. Social stigma associated with risky sexual be-
haviour in women may augment social problems and
limit occupational opportunities. In combination with
low self-esteem, this may render women with ADHD
vulnerable to sexual harassment, exploitation, and/
or abusive or inappropriate relationships. The Adult Psy-
chiatric Morbidity household survey conducted in Eng-
land found that 27% of females who experienced
extensive physical and sexual violence had ADHD traits
[189].
The bulk of household, and parental and caring duties
are often borne by women [190–192], reflecting social
and cultural constraints and expectations. These may re-
sult in increased impairment and anxiety in relation to
these roles and duties in women compared with men.
The consensus group identified that the demands placed
on mothers often differ from those of fathers and that
low self-esteem may be related to perceived failure to
reach societal expectations. Mothers may lack confi-
dence or experience feelings of guilt over their perceived
inadequacy as a parent. Dysfunctional beliefs of this na-
ture may be reinforced if they have a difficult-to-manage
child with ADHD and are offered ‘parent training’ inter-
ventions. The group acknowledged that the term ‘parent
training’ is unhelpful and may be perceived as pejorative.
However, at the same time harsh, lax or negative par-
enting styles have been identified to be elevated in
mothers with ADHD [193]. Mothers with ADHD may
benefit from life skills coaching, guidance and support in
parenting, including ancillary support around parenting
strategies. This may be particularly helpful for more vul-
nerable mothers: those that are young, are sole care-
givers for their children, and/or are parenting a child
with ADHD. Tailored assessments, support plans and
social interventions may help to improve outcomes for
this vulnerable group.
Women with ADHD may experience problems in the
workplace, such as disorganisation, forgetfulness, in-
attention, accepting constructive criticism and appraisal,
and difficulties managing interpersonal relationships
with colleagues. This is likely to be exacerbated in the
presence of concurrent intellectual dysfunction and/or
other comorbidity. For these types of problems, often a
group intervention is helpful and cost-effective. However
the decision of whether a group or individualised ap-
proach is preferable should be based on careful formula-
tion and individual need. Women may also benefit from
targeted support in managing feelings of stress and dis-
tress, managing and regulating emotions, coping with re-
jection and/or feelings of isolation, managing
interpersonal conflict, assertiveness training, comprom-
ise and negotiation steps, which may help to improve
their occupational outcomes and their ability to cope
with everyday social interactions.
Multi-agency liaison
This section addresses issues that arise at a broader in-
stitutional level. Primarily, support for females with
ADHD may be improved through the psychoeducation
and training of individuals who work within these insti-
tutions. Some may act as referral gatekeepers and, as
such, they have the potential to support or hinder the
referral process and to positively or negatively influence
the progress of young people and adults within these in-
stitutions. A brief summary of multi-agency liaison rec-
ommendations is presented in Table 6.
Educational considerations and adjustments
ADHD is associated with low educational attainment
and academic underachievement [99, 146, 195]. Inter-
ventions should focus on supporting attendance and
engagement with education to avoid early school
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leaving, diminished educational attainment, and asso-
ciated vulnerabilities. Since ADHD is classified as a
disability under the UK Equality Act [196], reasonable
adjustments to education provision are mandated (ex-
amples may include: additional examination time, aca-
demic coaching, rest-breaks during examination, or
possibility for part-time study [197]). Research sug-
gests that simple interventions, including physical ad-
justments (table set-up, creating a time-out corner),
and behaviour management techniques, as well as
joint goal setting with primary age children, can help
to improve ADHD symptoms, social and emotional
functioning, and reduce conduct problems in the
classroom [198]. However, adjustments cannot be put
in place unless ADHD is first recognised and
diagnosed.
Young people affected by ADHD are at increased risk
for repeating grades, dropping out of high school, being
suspended or expelled, and failing to obtain school or
higher education qualifications [85, 99, 199]. Maintain-
ing strong links with school is key to promoting adoles-
cent health and social development [110]. Whilst early
or unplanned pregnancy is associated with a reduction
in educational and occupational opportunities, school
achievement problems in adolescent girls with ADHD
have also been shown to predate and predict risky sexual
behaviour and unplanned pregnancy [200]. The consen-
sus group noted that exclusion, truancy and school pho-
bia are associated with increased vulnerability of teenage
girls with ADHD in relation to later substance misuse,
antisocial behaviour, criminality, sexual exploitation and
early pregnancy. There is a danger that punitive mea-
sures may be harsher for girls who display hyperactive
or disruptive symptoms, due to this behaviour constitut-
ing a greater violation of social norms and expectations.
Excessive punitive measures can lead to loss of engage-
ment with education. Disciplinary problems (e.g. suspen-
sions, verbal or written warnings or expulsions) predict
earlier discontinuation of education in boys with ADHD
[201], although disciplinary problems are less commonly
reported in girls [85].
Externalising conditions have a stronger impact on be-
haviour in class, whilst internalising problems may im-
pact on motivation and ability to engage in education.
Girls with ADHD may present as easily distracted, disor-
ganised, overwhelmed and lacking in effort or motiv-
ation. Inattention is more highly predictive of
educational under-achievement compared with hyper-
activity [202, 203]. Females who are more likely to have
the diagnosis missed or misdiagnosed, may be particu-
larly disadvantaged since treatment with ADHD medica-
tion has been found to mediate educational outcome.
For example, a large-scale study of cross-sectional and
longitudinal data in ~10,000 12-year old twins from the
Netherlands Twin Register showed the potential efficacy
of treatment on academic outcomes [203]. Children tak-
ing ADHD medication scored significantly higher on an
Table 6 Multi-agency liaison for ADHD in girls and women: key
recommendations
Educational considerations and adjustments
• Training to improve ADHD detection and referral should be provided
across teaching and non-teaching educational staff.
• Students who have or who are suspected of having specific learning
difficulties should be screened for ADHD, since young people with
ADHD may also present with difficulties in reading and writing.
• Reasonable adjustments to education provision should be
implemented for students with ADHD (e.g. more examination time).
• Technology Enhanced Learning may support academic and
psychosocial education.
• Proactive planning regarding educational transitions should be made
with the student with ADHD, the school and others involved in the
student’s care, as appropriate.
• Flexible learning systems and support with childcare needs may help
women with ADHD return to education after having a baby.
• Career planning should consider non-linear progressions in education
and employment, taking into account strengths and weaknesses rather
than focusing on current performance.
Occupational considerations and adjustments
• Women who disclose their disability to their employer are entitled to
reasonable adjustments to the workplace in relation to their needs.
• Additional psychoeducational support may be required to help
women manage social and occupational demands in the workplace.
• Diaries, itineraries, lists, reminder notes and similar scaffolding
techniques can be adapted to individual needs through a wide range of
digital apps currently available at low or no cost.
• Returning to or starting work for the first time after children may be
a challenge for young women with ADHD.
Social care
• Training to improve ADHD detection and referral should be provided
to staff in all social, family and foster care services.
• All children at risk of entering the care system should be
systematically screened for developmental disorders, including ADHD.
• Staff should understand that parenting difficulties may be attributed
to undiagnosed ADHD rather than a chaotic lifestyle choice, and
understand that family members may share symptoms and suffer with
associated impairments.
• Social and family services will benefit from training on
psychoeducational input to support young mothers of ADHD children
and/or young mothers with ADHD (i.e. to develop skills and coping
strategies to help them manage their own mental health and personal
needs and those of their child).
Criminal justice system
• Training to improve ADHD detection and referral should be provided
to individuals working in the criminal justice system.
• Females with ADHD who are in the criminal justice system are
unlikely to have a prior diagnosis of ADHD.
• Full recommendations are provided in a previous consensus meeting
[194].
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educational achievement test than children with ADHD
who did not.
Individuals with ADHD and intellectual impairments,
both male and female, present with complex needs that
make it harder for them to engage in education. Many
young people with ADHD will have associated specific
learning difficulties such as dyslexia, dyscalculia and dys-
graphia. Presenting problems may be attributed solely to
these specific learning difficulties and/or ASD because
school staff are more familiar with them and have a
more limited knowledge about ADHD. It may be helpful
for students (at all levels of education) who have or who
are suspected of having specific learning difficulties to
be screened for ADHD, since young people with ADHD
may also present with difficulties in reading and writing.
It is important that both child and adult educational
professionals have an understanding of ADHD in girls
and young women, recognise its presentation and associ-
ated vulnerabilities, and have access to screening tools.
Training should be disseminated broadly across school
staff, including teachers and special educational needs
coordinators, as well as teaching assistants, school lunch
aides, and after-school club staff who are more likely to
supervise children during less structured periods of the
day or during one-to-one work in classrooms. It is im-
portant that key personnel avoid over-simplistic caus-
ation when assessing individual needs (e.g. focusing on
their family situation) and understanding of the bi-
directional nature of ADHD difficulties in terms of fam-
ily relationships.
All educational staff should be trained in how to
screen females for ADHD and how to make onward re-
ferrals for treatment, if indicated. School staff should be
trained on the importance of early detection, educational
needs and interventions and support strategies that can
improve educational outcomes. Training sessions should
raise awareness of the current bias towards males in the
clinical referral process. Teaching staff may not be as
aware of the benefits of referral and ADHD treatment in
girls [45], and children with the inattentive subtype
[204]. Addressing gender-specific ADHD issues, and
gender expectations and stereotypes may help staff to
better identify affected females. If ADHD is suspected,
schools may consider adopting sensitive screening tools
for ADHD (Table 4) or broader mental health problems
(e.g. the SDQ [116]). These tend to be cost-effective,
quick and reliable, and can help to identify vulnerable
girls and young women. Difficulties can arise in main-
taining medication treatment programmes in school and
staff should be mindful that children may find this stig-
matising, especially those who require short-acting med-
ications to be dispensed at school.
Many of the training needs for educational staff re-
main the same in secondary as in primary school.
However, transition to secondary school is accompanied
by increased academic demands, and increased require-
ment for self-organisation and personal responsibility
against a backdrop of navigating a new social environ-
ment. Young people with ADHD are likely to find this
shift in self-management and responsibility especially
challenging. ADHD symptoms may become exacerbated
and more noticeable, triggering referral for the first time.
Good learning and teaching practices (i.e. not necessarily
ADHD specific) may help to mitigate many of the poten-
tial issues in the classroom by promoting engagement,
increasing on-task behaviour and reducing social
friction.
Efforts toward Technology Enhanced Learning or e-
Learning, are likely to be especially helpful for young
people with ADHD. With the appropriate content and
support, these learning resources have the potential to
go beyond improving academic outcomes in secondary
school by improving psychosocial functioning (e.g. help-
ing young people to acquire skills to manage risks of ex-
ploitation, bullying and/or victimisation in the school
environment or online via social media and communica-
tion platforms). Although further research is required to
determine the efficacy of e-learning methods for improv-
ing outcomes in ADHD, specific examples of successful
application of these technologies have been reported
(reviewed in [205]).
Careers advice should consider the strengths and
weaknesses of female students rather than focus solely
on current performance, bearing in mind the relative de-
velopmental delay, underachievement, immaturity (and
sometimes naivety) of young people with ADHD. Re-
search indicates that occupational ‘fit’ can serve to ex-
acerbate or reduce impairments associated with ADHD.
For example, some individuals with ADHD show a pref-
erence for more stimulating environments, active,
hands-on, or busy and fast-paced jobs [206]. Career
planning that incorporates work experience, non-linear
progression towards tertiary education and opportunities
to re-sit exams or demonstrate potential may be benefi-
cial for those who have struggled to sustain their engage-
ment in a formal school setting.
Guidance for those wishing to embark in further
education should take account of the course demands
involved (e.g. level of coursework, method of examin-
ation). For those who move away from home, transi-
tion is further complicated by the many challenges
involved in independent living such as financial man-
agement, taking responsibility for domestic and occu-
pational arrangements and healthcare. Moving away
from home often escalates social demands, with pres-
sure to integrate with people of different ages, cul-
tural backgrounds and interests. It is essential that
young people with ADHD make supportive links
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within the educational organisation (e.g. disability ser-
vices or student support services) who can support
them to access the help to meet their needs, and co-
ordinate with primary health services. This needs to
be planned and thought through in advance because
a lack of structure and support at this key stage of
transition may unveil or amplify ADHD symptoms,
together with associated clinical and functional im-
pairments. Adequate support can help young people
with ADHD access additional resources. For example,
students with ADHD in further or higher education
can apply for Disabled Students Allowance (https://
www.gov.uk/disabled-students-allowances-dsas), which
can fund assistive technology (e.g. speech to text soft-
ware), specialist mentoring (to help with organisa-
tional and planning skills) and “academic coaching”.
In general young people with ADHD reach or
complete higher education at a later age than their peers
[201]. This can be due to having to repeat years, re-take
modules, and obtain extensions for coursework. Many
drop out early due to educational or social problems, or
early pregnancy. This emphasises the importance for
young people having the opportunity to re-access educa-
tion in later years. However whilst special educational
needs support may be available up to age 25 in the UK,
women with unrecognised ADHD may experience diffi-
culties in accessing these provisions or meeting eligibility
criteria for learning difficulties. Flexible learning systems
and support with childcare are helpful initiatives, e.g. in
the UK women with children who wish to return to edu-
cation can obtain childcare support through government
initiatives, such as Care to Learn (https://www.gov.uk/
care-to-learn), and Childcare Grants (https://www.gov.
uk/childcare-grant).
Occupational considerations and adjustments
In adulthood, ADHD is associated with unemployment
or working in unskilled occupations [201], difficulty
maintaining jobs [99, 201], and impaired work perform-
ance and financial stress [207]. A longitudinal study fol-
lowing up girls age from eight until age 30, found that
women with childhood ADHD were more likely than
their peers to have no or few qualifications, be in poorly
paid employment, claim benefits, live in temporary or
social housing and have a low income [68].
ADHD qualifies as a disability under the UK Equality
Act 2010 [196], because it can have a substantial and
long-term impact on a person’s ability to perform day-
to-day activities. This status can afford women with
ADHD certain rights, and access to certain services. For
women with ADHD commencing employment, add-
itional support may be required regarding the decision
to disclose they have a disability. They may need support
in understanding the demands of an organisation, the
work-role and personnel structure, how to manage inter-
personal conflict, and guidance on how to manage their
time, plan and prioritise tasks. Diaries, itineraries, lists,
reminder notes and similar scaffolding techniques can
be adapted to individual needs through a wide range of
digital apps currently available at low or no cost.
Women with ADHD may experience particular diffi-
culty returning to work after having children. This is as-
sociated with employment penalties linked to
educational problems and potentially having left school
early with few or no qualifications. Initiatives such as
Specialist Employability Support (https://www.gov.uk/
specialist-employability-support) are available to provide
intensive support and training for unemployed people
with a disability.
Occupational difficulties may be further compounded
by a difficulty managing the effects of persisting ADHD
symptoms on job-related and social performance in the
workplace, together with the need to balance occupa-
tional demands with childcare. Reasonable adjustments
in the workplace may be helpfully put in place [208] but
these may only be achieved if women with ADHD elect
to disclose they have a disability. This may not be an
easy decision as the individual must balance the need to
optimise the environment against their fear of social and
occupational stigma, the latter including the possibility
they may be held back in promotion and/or other career
advancement.
On the other hand, disclosing a disability allows for
women with ADHD to be treated more favourably under
the UK Equality Act 2010 [196], and benefit from rea-
sonable adjustments that remove barriers in the work-
place that would otherwise disadvantage them.
Reasonable adjustments are assessed on a case by case
basis and extra support for the costs of making reason-
able adjustments in the workplace can come from the
Access to Work government initiative (see: https://www.
gov.uk/access-to-work ). These rights apply to women
with ADHD returning to work, taking up employment
or becoming diagnosed at any time during their working
lives. Employers who fail to comply with this duty would
be liable for disability discrimination.
Health and social care
Research suggests an increased involvement of ADHD
children with the social care and foster care systems
[209, 210]. Equipping social care professionals with tools
similar to those used in school settings (e.g. the SDQ)
may promote a higher level of insight and understand-
ing. Males may be overrepresented in these systems due
to high rates of comorbidity with disruptive behavioural
problems. Females with ADHD may be more likely to
come into contact with social services if they are young
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single parents struggling with child-care responsibilities;
however their underlying ADHD may be unrecognised.
The overrepresentation of developmental disorders in
the care population may be the result of a failure in
existing services to recognise the specific contribution of
these conditions to family breakdown, and an absence of
targeted support in such cases. The group recommends
that all children at risk of entering the care system
should be systematically screened for developmental dis-
orders. Social care professionals may struggle to identify
the parenting potential in undiagnosed women with
ADHD, and attribute difficulties more to a chaotic life-
style choice rather than to any underlying disorder.
Given the high heritability rates [132] it is also helpful to
consider that other family members may also share
symptoms and suffer with associated impairments, when
examining family dynamics.
Social and family services will benefit from training so
they can provide specific psychoeducational input to
support young mothers of ADHD children and young
mothers with ADHD. If deemed appropriate, they might
refer mothers with ADHD to mental health services for
targeted support that aims to develop skills and coping
strategies, and to help them manage their own mental
health and personal needs and those of their child.
The early sexual activity, promiscuity and higher risk
for sexually transmitted diseases in some females with
ADHD is likely to increase contact with sexual health
clinics. ADHD training should therefore be extended to
include service-providers at these clinics in order to raise
awareness of the presentation and needs of females with
ADHD. For example this may lead to better understand-
ing of the need for additional sexual health education,
including digital health education, which in turn may
better support these young women and prevent sexual
exploitation.
Criminal justice system
Increased rates of delinquent or criminal behaviour may
lead to contact with the criminal justice system [107].
Prevalence of ADHD in incarcerated populations is high,
estimated at around one quarter (25.5%) but with no sig-
nificant differences overall in relation to gender or age.
There is however a lower prevalence in adult women
than men (22.1% in female adults v. 31.2%, male adults),
whereas female youths have a similar prevalence to male
youths (30.8% and 29.5%, respectively) [107]. One study
reported that only 18.8% of male adult offenders diag-
nosed with ADHD in prison had a prior diagnosis of
ADHD [211]. It is likely that this proportion is even
lower for females.
Evidence indicates that ADHD treatment is associated
with reduced rates of criminality [212], is tolerated and
effective in prison inmates [213], and improves their
quality of life and cognitive function [214]. This has led
to speculation that effective identification and treatment
of ADHD may help to reduce reoffending, albeit with
reservations surrounding potential for diversion or mis-
use of medications, treatment adherence, and discon-
tinuity of ADHD treatment after release [215]. Current
best practice recommendations for screening, identify-
ing, treating and supporting ADHD in prisoners and
youth offenders are provided in a previous review and
consensus report [194], with particular recommenda-
tions for support provided for female offenders.
Females with ADHD are likely to be perceived to devi-
ate substantially from stereotypical expectations of be-
haviour. The differential diagnosis between BPD and
ADHD may be particularly important for females in fo-
rensic settings, where a high rate of comorbidity has
been reported [216]. In the criminal justice system, in-
cluding prison, there may possibly be a more sympa-
thetic approach toward female offenders but, as for
males, their ADHD is unlikely to be recognised. The
group noted that ADHD is commonly perceived as ‘bad
behaviour’ rather than a vulnerability in this setting, per-
haps reflecting high rates of critical incidents (verbal and
physical aggression, damage to property, self-injury) be-
ing reported in prison [217]. This may be intensified in
female offenders with ADHD due to poor understanding
of the condition. Further research regarding the interface
between the criminal justice system and females with
ADHD is needed.
Discussion
Over 30 years ago, Berry, Shaywitz and Shaywitz warned
that girls constitute a ‘silent minority’ in ADHD, with
more internalised behaviour making them less likely to
be referred for assessment [36]. This does not appear to
have changed. Females with ADHD remain more likely
to be unrecognised or mis-identified leading to lower
than expected rates of referral, assessment and treatment
for ADHD. Whilst this has been attributed to the higher
rate of internalised and inattentive only presentation in
girls, this omission is remarkable, given that the predom-
inantly inattentive subtype of ADHD has been endorsed
by the Diagnostic and Statistical Manual, a key diagnos-
tic tool, for many years.
There are specific barriers that seem to hinder the rec-
ognition of ADHD in girls and women. These include
symptomatic differences, gender biases due to stereotyp-
ical expectations, comorbidities and compensatory func-
tions, which mask or overshadow the effects of ADHD
symptoms. There is strong public perception that
ADHD is a behavioural disorder that primarily affects
males. Hence the challenge is to raise awareness and
provide training on the presence and presentation of
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ADHD in females to agencies that regularly interface
with children, young people and adults.
The current health and social care system appears to
be better geared toward identifying and treating ADHD
presenting alongside behavioural and externalising prob-
lems, in particular those that present as overt, disruptive
and aggressive in nature, and are more commonly seen
in boys and men. It is erroneous to consider that females
do not present with hyperactive and impulsive symp-
toms – they do. However, these are generally less overt
and aggressive in nature than the conduct problems dis-
played by males and instead seem to relate to more
social-relational and psychosexual problems and behav-
iours. Understanding the expression of ADHD in fe-
males is the first step towards improving detection,
assessment, and treatment, and ultimately enhancing
long-term outcomes for girls and women with ADHD.
One of the most consistent topics discussed at the
consensus (and across all breakout groups) related to
how social-relational and psychosexual problems seem
to be more marked in females with ADHD compared
with males. Difficulties in managing and maintaining
functional interpersonal relationships hinder some girls
and women from developing or maintaining a positive
social network or accessing peer support. ADHD symp-
toms and emotional lability seem to be related to dys-
functional coping strategies and dissatisfaction with life
[77]. Lack of planning for the future [86] may mean that
girls and women with ADHD lack constructive activities
and occupations in adulthood. These effects may lead to
affected girls and women becoming overwhelmed, anx-
ious and low in mood. In turn they may respond by ap-
plying dysfunctional coping strategies, such as self-harm
and substance use.
Females with ADHD overall have an earlier onset of
sexual activity, more sexual partners, and an increased
risk of contracting sexually transmitted infections or
having an unplanned pregnancy. They are at risk of
sexual exploitation, perceived exhibitionism or being
considered promiscuous. Social stigma associated with
risky sexual behaviour in women may augment social
problems, and render affected women vulnerable to
being victimised, bullied, harassed, abused, or entering
into unhealthy relationships. Young girls with ADHD
may become young mothers with ADHD (and pos-
sibly also mothers of children with ADHD). This is
associated with a further reduction in educational and
occupational opportunities. Research is needed to
tease out the motivations and causal mechanisms of
these behaviours and outcomes in females with
ADHD, and if, how and why they may differ from
those of males.
Treatment has been reported to moderate the life-
time risks of ADHD for both males and females. The
consensus group identified where adjustments to ap-
proaches in treatment are needed to better support
girls and women with ADHD. This includes more fre-
quent treatment monitoring and psychoeducation at
times of personal transition, with a greater focus on
functional and emotional aspects of the disorder. The
consensus group considered that multi-agency liaison
will also be needed to support some girls and women
with ADHD. Furthermore, raising awareness of, and
providing training about, ADHD in institutions (e.g.
educational, social, family, sexual health and criminal
justice services) as well as the key healthcare system
(primary health, child and adolescent mental health
services and adult general psychiatry) will be helpful
to improve detection of girls and women with ADHD,
increase understanding and reduce stigma.
The consensus highlighted the relative dearth of re-
search on the life-span experience of females with
ADHD. Given the higher prevalence of ADHD in males,
it would be helpful if studies reporting sex-mixed co-
horts segregated data and results by gender. This would
be particularly helpful in large clinical or population-
based studies, where information on girls with ADHD
would otherwise be buried as variance under the pre-
dominant male group. Providing sex-segregated results
and data for all studies of ADHD (perhaps under supple-
mentary data) would provide information to inform fu-
ture meta-analyses.
Future research should investigate the presentation
and needs of females with ADHD: how they might better
be identified and assessed, and how their treatment re-
sponse should best be evaluated and monitored to ef-
fectively improve outcomes. The most recent meta-
analyses of gender differences in ADHD symptom pres-
entation and associated features was reported over 15
years ago. An updated meta-analysis including all recent
data is now needed. More research is also required to
elucidate the interaction of hormones, ADHD symptoms
and stimulant medication on functioning during key
times of hormonal change (e.g. during the menstrual
cycle, pregnancy and the postpartum period, and meno-
pause), to help inform treatment plans. Factors that are
associated with hyperactive/impulsive symptoms in fe-
males with ADHD and how these differ to males should
be investigated further, including sexual behaviours and
their motivations in girls and women with ADHD, as
well as vulnerabilities to victimisation, physical and sex-
ual assault and cyberbullying.
Conclusions
This consensus will inform effective identification, treat-
ment and support of girls and women with ADHD. To
facilitate identification, it is important to move away
from the previously predominating ‘disruptive boy’
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stereotype of ADHD and understand the more subtle
and internalised presentation that predominates in girls
and women. In treatment, it is important to consider a
lifespan model of care for females with ADHD, which
supports the complex and developmentally changing
presentation of ADHD in females. Appropriate interven-
tion is expected to have a positive impact on affected
girls and women with ADHD, their families, and more
broadly on society leading to increased productivity, de-
creased resource utilization and, most importantly, bet-
ter outcomes for girls and women.
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